PortfoliosLab logoPortfoliosLab logo
OCUL vs. AIQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

OCUL vs. AIQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ocular Therapeutix, Inc. (OCUL) and Global X Artificial Intelligence & Technology ETF (AIQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OCUL achieves a -31.22% return, which is significantly lower than AIQ's 35.98% return.


OCUL

1D
0.48%
1M
-14.53%
YTD
-31.22%
6M
-27.14%
1Y
0.24%
3Y*
6.46%
5Y*
-10.45%
10Y*
-3.44%

AIQ

1D
-1.40%
1M
21.10%
YTD
35.98%
6M
36.15%
1Y
69.19%
3Y*
37.50%
5Y*
19.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

OCUL vs. AIQ - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
OCUL
Ocular Therapeutix, Inc.
-31.22%42.15%91.48%58.72%-59.68%-66.33%424.05%-0.75%-42.49%
AIQ
Global X Artificial Intelligence & Technology ETF
35.98%31.89%24.11%55.39%-36.44%17.09%52.88%39.94%-14.03%

Correlation

The correlation between OCUL and AIQ is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.34

Correlation (All Time)
Calculated using the full available price history since May 17, 2018

0.34

The correlation between OCUL and AIQ shifts across timeframes, from 0.23 (1 year) to 0.34 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OCUL vs. AIQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OCUL
OCUL Risk / Return Rank: 4141
Overall Rank
OCUL Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
OCUL Sortino Ratio Rank: 4343
Sortino Ratio Rank
OCUL Omega Ratio Rank: 4242
Omega Ratio Rank
OCUL Calmar Ratio Rank: 4040
Calmar Ratio Rank
OCUL Martin Ratio Rank: 4040
Martin Ratio Rank

AIQ
AIQ Risk / Return Rank: 8181
Overall Rank
AIQ Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
AIQ Sortino Ratio Rank: 8181
Sortino Ratio Rank
AIQ Omega Ratio Rank: 8080
Omega Ratio Rank
AIQ Calmar Ratio Rank: 8080
Calmar Ratio Rank
AIQ Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OCUL vs. AIQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ocular Therapeutix, Inc. (OCUL) and Global X Artificial Intelligence & Technology ETF (AIQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OCULAIQDifference
Sharpe ratioReturn per unit of total volatility

-3.02

Sortino ratioReturn per unit of downside risk

-3.15

Omega ratioGain probability vs. loss probability

1.07

1.49

-0.42

Calmar ratioReturn relative to maximum drawdown

0.00

4.22

-4.22

Martin ratioReturn relative to average drawdown

0.01

14.59

-14.58

OCUL vs. AIQ - Sharpe Ratio Comparison

The current OCUL Sharpe Ratio is 0.00, which is lower than the AIQ Sharpe Ratio of 3.02. The chart below compares the historical Sharpe Ratios of OCUL and AIQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


OCULAIQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.00

3.02

-3.02

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.13

0.76

-0.89

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.04

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

0.84

-0.89

Drawdowns

OCUL vs. AIQ - Drawdown Comparison

The maximum OCUL drawdown since its inception was -95.19%, which is greater than AIQ's maximum drawdown of -44.66%. Use the drawdown chart below to compare losses from any high point for OCUL and AIQ.


Loading charts...

Drawdown Indicators


OCULAIQDifference

Max Drawdown

Largest peak-to-trough decline

-95.19%

-44.66%

-50.53%

Max Drawdown (1Y)

Largest decline over 1 year

-57.29%

-16.47%

-40.82%

Max Drawdown (3Y)

Largest decline over 3 years

-72.77%

-26.35%

-46.42%

Max Drawdown (5Y)

Largest decline over 5 years

-86.17%

-44.66%

-41.51%

Max Drawdown (10Y)

Largest decline over 10 years

-90.94%

Current Drawdown

Current decline from peak

-80.70%

-1.40%

-79.30%

Average Drawdown

Average peak-to-trough decline

-76.62%

-9.80%

-66.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.86%

4.76%

+24.10%

Volatility

OCUL vs. AIQ - Volatility Comparison

Ocular Therapeutix, Inc. (OCUL) has a higher volatility of 16.12% compared to Global X Artificial Intelligence & Technology ETF (AIQ) at 8.60%. This indicates that OCUL's price experiences larger fluctuations and is considered to be riskier than AIQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OCULAIQDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.12%

8.60%

+7.52%

Volatility (6M)

Calculated over the trailing 6-month period

59.66%

18.46%

+41.20%

Volatility (1Y)

Calculated over the trailing 1-year period

69.33%

23.04%

+46.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.34%

25.33%

+53.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

79.92%

25.50%

+54.42%

Dividends

OCUL vs. AIQ - Dividend Comparison

OCUL has not paid dividends to shareholders, while AIQ's dividend yield for the trailing twelve months is around 0.14%.


PositionTTM20252024202320222021202020192018
AIQ
Global X Artificial Intelligence & Technology ETF
0.14%0.18%0.14%0.16%0.56%0.15%0.50%0.51%0.51%
OCUL
Ocular Therapeutix, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


OCUL and AIQ have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OCUL has higher volatility (16.12%) compared to AIQ (8.60%). In terms of maximum drawdown, OCUL dropped -95.19% vs AIQ's -44.66%.

AIQ currently has the higher Sharpe Ratio (3.02 vs 0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OCUL and AIQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer